Qinggang Tan

Dr. Qinggang Tan


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
QTQinggang Tan
Qinggang Tan
SLSonggang Li
Songgang Li
JRJie Ren
Jie Ren
CCChu Chen
Chu Chen
Macroporous scaffolds with controllable pore structure and mechanical properties were fabricated by a porogen fusion technique. Biodegradable material poly (D, L-lactide) (PDLLA) was used as the scaffold matrix. The effects of porogen size, PDLLA concentration and hydroxyapatite (HA) content on the scaffold morphology, porosity and mechanical properties were investigated. High porosity (90% and above) and highly interconnected structures were easily obtained and the pore size could be adjusted by varying the porogen size. With the increasing porogen size and PDLLA concentration, the porosity of scaffolds decreases, while its mechanical properties increase. The introduction of HA greatly increases the impact on pore structure, mechanical properties and water absorption ability of scaffolds, while it has comparatively little influence on its porosity under low HA contents. These results show that by adjusting processing parameters, scaffolds could afford a controllable pore size, exhibit suitable pore structure and high porosity, as well as good mechanical properties, and may serve as an excellent substrate for bone tissue engineering.

1 March 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XWXuefeng Wang
Xuefeng Wang
SLSonggang Li
Songgang Li
ZWZiwei Wan
Ziwei Wan
ZQZhiwei Quan
Zhiwei Quan
QTQinggang Tan
Qinggang Tan

20 June 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
WXWei Xu
Wei Xu
QTQinggang Tan
Qinggang Tan
MYMiao Yu
Miao Yu
QSQiang Sun
Qiang Sun
HKHuihui Kong
Huihui Kong
FBFlemming Besenbacher
Flemming Besenbacher
The atomic-scale identification of the G4K1 structural motif is achieved using an interplay of STM imaging and DFT calculations. Its high stability is found to be caused by the delicate balance between hydrogen bonding and metal–ligand interaction, which is of utmost relevance to model interactions of the G-quadruplex with cations in vivo.

7 December 2022 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
FGFukang Gui
Fukang Gui
QJQiu Jin
Qiu Jin
DXDongdong Xiao
Dongdong Xiao
ZJZehua Jin
Zehua Jin
YZYingchuan Zhang
Yingchuan Zhang
QXQiangfeng Xiao
Qiangfeng Xiao
A hybrid catalyst constituting single-atom FeN2 and Co3O4 nanoparticles exhibits superior bifunctional electrocatalytic activities towards the oxygen reduction reaction (ORR) and oxygen evolution reaction (OER).

16 February 2017 in Materials
Verified
Journal Article
Open access
PDF file
QTQinggang Tan
Qinggang Tan
YCYanyan Chu
Yanyan Chu
MBMin Bie
Min Bie
ZWZihao Wang
Zihao Wang
小徐小燕 徐
小燕 徐
Biopolymer/inorganic material nanocomposites have attracted increasing interest as nanocarriers for delivering drugs owing to the combined advantages of both biopolymer and inorganic materials. Here, amphiphilic block copolymer/fullerene nanocomposites were prepared as nanocarriers for hydrophobic drug by incorporation of C60 in the core of methoxy polyethylene glycol-poly(d,l-lactic acid) (MPEG-PDLLA) micelles. The structure and morphology of MPEG-PDLLA/C60 nanocomposites were characterized using transmission electron microscopy, dynamic light scattering, high-resolution transmission electron microscopy, and thermal gravimetric analysis. It was found that the moderate amount of spherical C60 incorporated in the MPEG-PDLLA micelles may cause an increase in the molecular chain space of PDLLA segments in the vicinity of C60 and, thus, produce a larger cargo space to increase drug entrapment and accelerate the drug release from nanocomposites. Furthermore, sufficient additions of C60 perhaps resulted in an aggregation of C60 within the micelles that decreased the drug entrapment and produced a steric hindrance for DOX released from the nanocomposites. The results obtained provide fundamental insights into the understanding of the role of C60 in adjusting the drug loading and release of amphiphilic copolymer micelles and further demonstrate the future potential of the MPEG-PDLLA/C60 nanocomposites used as nanocarriers for controlled drug-delivery applications.

4 July 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
XXXiao-Yan Xu
Xiao-Yan Xu
YCYan-Fang Chen
Yan-Fang Chen
QTQinggang Tan
Qinggang Tan
ZCZhi-Jie Chen
Zhi-Jie Chen
YLYan Li
Yan Li
YLYing Bin Liu
Ying Bin Liu
The construction of antibacterial and antitumor coatings could offer effective routes to improve the therapeutic effects of non-vascular stents for unresectable obstructions caused by malignant tumours. Herein, polyelectrolyte multilayers have been explored as bactericidal coatings with controlled antitumor drug release. To solve the challenges of loading and controlled release of small-molecule chemotherapeutic drugs in polyelectrolyte multilayers, the antitumor drug doxorubicin (DOX) was chemically conjugated onto polyethylenimine via cis aconitic anhydride (pH-sensitive linker), thus obtaining the polycation prodrug PEI-CA-DOX. Alginate sodium was oxidized (O-Alg) and mixed with DOX to prepare the O-Alg-DOX complex as a polyanion. QCM-D and contact angle tests were used to monitor and verify the progressive build-up of the PEI-CA-DOX/O-Alg-DOX multilayer films, which show a linear growth. The in vitro antibacterial tests indicated that the PEI-CA-DOX-terminated PEI-CA-DOX/O-Alg-DOX multilayers could kill the bacteria effectively. As-such multilayers also presented a long-term sustained DOX release behaviour in PBS due to the combination of slow release in PEI-CA-DOX and fast release in the O-Alg-DOX complex. The as-designed PEI-CA-DOX/O-Alg-DOX multilayers with combined antibacterial and antitumor properties may have great potential for applications in non-vascular stent coatings for palliative treatment of obstruction caused by malignant tumours.